06/21/2022: Lab Advisory: Interagency Partners Update Planning Guidance for Disposal and Shipment of Material Suspected to Contain Mpox Virus
Audience: Clinical Laboratory Professionals
Level: Laboratory Advisory
Interagency partners at the U.S. Transportation, Labor, and Defense departments, the U.S. Environmental Protection Agency, CDC, and the Assistant Secretary for Preparedness and Response have updated the planning guidance for handling category A solid waste, which addresses the transportation and disposal of material suspected to contain mpox virus.
Previous studies have defined two distinct mpox clades, West African and Congo Basin, with unique disease manifestations (i.e., how disease presents in people, the severity of its effects, and how readily it spreads). Human disease associated with West African clade mpox virus infection is less severe and associated with less human-to-human transmission compared to infections with Congo Basin clade mpox virus. Therefore, recommendations for packing, shipping, inactivation methods, and managing waste contaminated with mpox virus differ based on the clade of the virus.
All currently known mpox cases in the United States are of the West African clade. As long as clinical teams can reasonably determine that it holds true for the specific patient they are caring for (i.e., because of disease presentation, epidemiologic linkage to a case known to have West African clade mpox, no travel history to a country where Congo Basin clade mpox virus is known to circulate), then materials known or suspected to contain only West African clade mpox virus can be classified at lower levels (i.e., below Category A) under the Hazardous Materials Regulations (HMR).
Waste can be packed, transported, treated/inactivated, and disposed of as United Nations (UN) 3291, Regulated Medical Waste (RMW) under the HMR and any applicable state, tribal, local, or territorial regulations—the same way other waste from healthcare facilities is routinely managed.
Laboratory specimens can be packed and shipped as Category B infectious substances (UN 3373, Biological Substance, Category B). Specimens suspected to contain only West African clade mpox virus do not require a DOT Special Permit.
Note: Public health laboratories have capacity for the current testing demand. Laboratories with specimens that are suspected to contain mpox virus should contact their state or territorial public health department (contact list) as soon as possible.
Opt in to receive updates from the CDC Laboratory Outreach Communication System (LOCS).
Online resources:
- Transporting Infectious Substances Safely (DOT)
- Planning Guidance for Handling Category A Solid Waste (PHMSA)
See table in appendix F-2 on page 94-95 for differences in procedures for West Africa clade and Congo Basin clade - Mpox – Information for Laboratory Personnel
- U.S. Mpox 2022: Situation Summary
- Real-time PCR assays for the specific detection of mpox virus West African and Congo Basin strain DNA
- Detection of mpox virus with real-time PCR assays
Questions?
- If you are a clinical or public health laboratory professional, contact LOCS.
- For media inquiries, contact the CDC Newsroom.
- For all other questions, contact CDC-INFO.
Thank you,
The Laboratory Outreach Communication System
Laboratory Outreach Communication System (LOCS) | Division of Laboratory Systems (DLS)
Center for Surveillance, Epidemiology, and Laboratory Services (CSELS)
Centers for Disease Control and Prevention (CDC)